Penta Valent
PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. It operates through Pharmaceutical Products and Consumer Goods segments. The company offers prescription medicinal products; over the counter drug products; medical supporting equipment, such as blood pressure meters, body thermometers, and others; reaction materials, such as blood sug… Read more
Penta Valent (PEVE) - Total Assets
Latest total assets as of September 2025: Rp1.32 Trillion IDR
Based on the latest financial reports, Penta Valent (PEVE) holds total assets worth Rp1.32 Trillion IDR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Penta Valent - Total Assets Trend (2022–2024)
This chart illustrates how Penta Valent’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Penta Valent - Asset Composition Analysis
Current Asset Composition (December 2024)
Penta Valent's total assets of Rp1.32 Trillion consist of 96.5% current assets and 3.5% non-current assets.
| Asset Category | Amount (IDR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0.7% |
| Accounts Receivable | Rp534.32 Billion | 45.9% |
| Inventory | Rp344.46 Billion | 29.6% |
| Property, Plant & Equipment | Rp25.84 Billion | 2.2% |
| Intangible Assets | Rp0.00 | 0.0% |
| Goodwill | Rp0.00 | 0.0% |
Asset Composition Trend (2022–2024)
This chart illustrates how Penta Valent's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Penta Valent's current assets represent 96.5% of total assets in 2024, an increase from 96.3% in 2022.
- Cash Position: Cash and equivalents constituted 0.7% of total assets in 2024, up from 0.0% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 45.9% of total assets.
Penta Valent Competitors by Total Assets
Key competitors of Penta Valent based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
Penta Valent - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Penta Valent generates 2.59x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Penta Valent generates $ 4.13 in net profit.
Penta Valent - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.34 | 1.35 | 1.35 |
| Quick Ratio | 0.92 | 0.92 | 0.92 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rp325.12 Billion | Rp 275.63 Billion | Rp 275.63 Billion |
Penta Valent - Advanced Valuation Insights
This section examines the relationship between Penta Valent's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 28.3% |
| Total Assets | Rp1.16 Trillion |
| Market Capitalization | $9.94 Million USD |
Valuation Analysis
Below Book Valuation: The market values Penta Valent's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Penta Valent's assets grew by 28.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Penta Valent (2022–2024)
The table below shows the annual total assets of Penta Valent from 2022 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Rp1.16 Trillion | +28.32% |
| 2023-12-31 | Rp906.74 Billion | +21.88% |
| 2022-12-31 | Rp743.96 Billion | -- |